Login

Join Now

How to Monetize R&D Tax Credits

Webinar May 6, 2021, 12:00 PM

The Employee Retention Credit is a refundable per employee tax credit of up to $5K in 2020 and $28K in 2021. Presented by BioUtah and Tanner, this webinar will help you learn how your company can take advantage of these programs to improve your cash flow.

Register

The voice of utah’s life sciences community

BioUtah is the common voice and flag bearer for Utah’s life sciences industry comprised of medical devices, pharmaceutical, diagnostics, and biotechnology. Together we form an ecosystem that fosters collaboration, promotes innovation and delivers technology that saves lives.

Learn More

Medical Device

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

May 14, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
ARUP Announces Partnership with TellBio for Use of TellBio’s Novel Circulating Tumor Cells Technology

ARUP Laboratories on May 10 announced it has signed a strategic agreement with Massachusetts-based TellBio Inc. to use the company’s TellDx circulating tumor cells (CTCs) technology in several research applications. ARUP has also invested in TellBio as part of the startup’s series A financing round. Other funding partners include Crocker Ventures, Genetron Holdings Ltd (NASDAQ: […]

May 14, 2021
BioUtah News Life Sciences Industry News Utah's Life Sciences Companies
Xenter Closes Series A at $12M; Adds Four Additional Board Members

Xenter has announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. “Xenter is transforming healthcare as an innovative Device-Data-Drug healthcare technologies startup,” said Kelvyn Cullimore, president and CEO of BioUtah. “The new additions to the board, including Utah life […]

May 14, 2021
Policy News
Who Develops Medicines? A New Study Highlights Role of Private Investment

Discussion around drug pricing often raises the issue of just how much NIH funding drives the development of new therapies. The general perception is that NIH funding is largely responsible for the creation and approval of new therapies. However, a new study by VitalTransformation (sponsored by BIO and PhRMA) finds that perception to be misguided. […]

See More BioUtah News

From Here to There

See how BioUtah, the only trade association dedicated solely to Utah’s Life Sciences industry, can help your business grow.


Networking

Advocacy

Investment

Workforce Development

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors